The dietary fat doctrine: Essential fatty acids in health and disease

The Fats of Life: Essential Fatty Acids in Health and Disease

Volumn , Issue , 2010, Pages 1-277

  Lawrence, Glen ^a  

^a LONG ISLAND UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84898589520     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Book

References (384)

1. Abedin, M., J. Lim, T. B. Tang, D. Park, L. L. Demer, and Y. Tintut. 2006. N-3 fatty acids inhibit vascular calcification via the p38-mitogen-activated protein kinase and peroxisome proliferator-activated receptor-gamma pathways. Circ Res 98(6):727-729.
2. Abedin, M., Y. Tintut, and L. L. Demer. 2004. Vascular calcification: Mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol 24(7):1161-1170.
3. Adams, J. M., and S. Cory. 1991. Transgenic models of tumor development. Science 254(5035):1161-1167.
4. Al, M. D., A. C. van Houwelingen, and G. Hornstra. 1997. Relation between birth order and the maternal and neonatal docosahexaenoic acid status. Eur J Clin Nutr 51(8):548-553.
5. Albanes, D., O. P. Heinonen, P. R. Taylor, J. Virtamo, B. K. Edwards, M. Rautalahti, A. M. Hartman, et al. 1996. Alpha-tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: Effects of base-line characteristics and study compliance. J Natl Cancer Inst 88(21):1560-1570.
6. Albert, M. A., E. Danielson, N. Rifai, and P. M. Ridker. 2001. Effect of statin therapy on C-reactive protein levels: The pravastatin inflammation/CRP evaluation (PRINCE): A randomized trial and cohort study. JAMA 286(1):64-70.
7. Alboni, P., E. Favaron, N. Paparella, M. Sciammarella, and M. Pedaci. 2008. Is there an association between depression and cardiovascular mortality or sudden death? J Cardiovasc Med (Hagerstown) 9(4):356-362.
8. Ames, B. N., and L. S. Gold. 1991. Carcinogenesis mechanisms: The debate continues. Science 252:902.
9. Antalis, C. J., L. J. Stevens, M. Campbell, R. Pazdro, K. Ericson, and J. R. Burgess. 2006. Omega-3 fatty acid status in attention-deficit/hyperactivity disorder. Prostaglandins Leukot Essent Fatty Acids 75(4-5):299-308.
10. Apostolski, S., Z. Marinkovic, A. Nikolic, D. Blagojevic, M. B. Spasic, and A. M. Michelson. 1998. Glutathione peroxidase in amyotrophic lateral sclerosis: The effects of selenium supplementation. J Environ Pathol Toxicol Oncol 17(3-4):325-329.
11. Appleton, K. M., R. C. Hayward, D. Gunnell, T. J. Peters, P. J. Rogers, D. Kessler, and A. R. Ness. 2006. Effects of n-3 long-chain polyunsaturated fatty acids on depressed mood: Systematic review of published trials. Am J Clin Nutr 84(6):1308-1316.
12. Asztalos, B. F., L. A. Cupples, S. Demissie, K. V. Horvath, C. E. Cox, M. C. Batista, and E. J. Schaefer. 2004. High-density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants of the Framingham Offspring Study. Arterioscler Thromb Vasc Biol 24(11):2181-2187.
13. Asztalos, B., M. Lefevre, L. Wong, T. A. Foster, R. Tulley, M. Windhauser, W. Zhang, and P. S. Roheim. 2000. Differential response to low-fat diet between low and normal HDL-cholesterol subjects. J Lipid Res 41(3):321-328.
14. Atkins, Robert C. 1972. Dr. Atkins' diet revolution. New York: Bantam Books.
15. Barter, P. J., S. Nicholls, K. A. Rye, G. M. Anantharamaiah, M. Navab, and A. M. Fogelman. 2004. Antiinflammatory properties of HDL. Circ Res 95(8):764-772.
16. Barzilai, N., G. Atzmon, C. Schechter, E. J. Schaefer, A. L. Cupples, R. Lipton, S. Cheng, and A. R. Shuldiner. 2003. Unique lipoprotein phenotype and genotype associated with exceptional longevity. JAMA 290(15):2030-2040.
17. Basciano, H., L. Federico, and K. Adeli. 2005. Fructose, insulin resistance, and metabolic dyslipidemia. Nutr Metab (Lond) 2(1):5.
18. Belury, M. A. 2002. Inhibition of carcinogenesis by conjugated linoleic acid: Potential mechanisms of action. J Nutr 132(10):2995-2998.
19. Berger, G. E., S. Smesny, and G. P. Amminger. 2006. Bioactive lipids in schizophrenia. Int Rev Psychiatry 18(2):85-98.
20. Berkow, R., ed. 1982. The Merck manual of diagnosis and therapy. 14th ed. Rahway, NJ: Merck, Sharp and Dohme Research Laboratories.
21. Berry, E. M. 1997. Dietary fatty acids in the management of diabetes mellitus. Am J Clin Nutr 66(4 Suppl):991S-997S.
22. Bilici, M., F. Yildirim, S. Kandil, M. Bekaroglu, S. Yildirmis, O. Deger, M. Ulgen, A. Yildiran, and H. Aksu. 2004. Double-blind, placebo-controlled study of zinc sulfate in the treatment of attention deficit hyperactivity disorder. Prog Neuropsychopharmacol Biol Psychiatry 28(1):181-190.
23. Black, P. N., and S. Sharpe. 1997. Dietary fat and asthma: Is there a connection? Eur Respir J 10(1):6-12.
24. Bombardier, C., L. Laine, A. Reicin, D. Shapiro, R. Burgos-Vargas, B. Davis, R. Day, et al. 2000. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 343(21):1520-1528.
25. Booth, F. W., M. J. Laye, S. J. Lees, R. S. Rector, and J. P. Thyfault. 2008. Reduced physical activity and risk of chronic disease: The biology behind the consequences. Eur J Appl Physiol 102(4):381-390.
26. Bordoni, A., M. Di Nunzio, F. Danesi, and P. L. Biagi. 2006. Polyunsaturated fatty acids: From diet to binding to ppars and other nuclear receptors. Genes Nutr 1(2):95-106.
27. Bough, K. J., and J. M. Rho. 2007. Anticonvulsant mechanisms of the ketogenic diet. Epilepsia 48(1):43-58.
28. Bourre, J. M. 2004. Roles of unsaturated fatty acids (especially omega-3 fatty acids) in the brain at various ages and during ageing. J Nutr Health Aging 8(3):163-174.
29. Braden, L. M., and K. K. Carroll. 1986. Dietary polyunsaturated fat in relation to mammary carcinogenesis in rats. Lipids 21(4):285-288.
30. Brehm, B. J., R. J. Seeley, S. R. Daniels, and D. A. D'Alessio. 2003. A randomized trial comparing a very low carbohydrate diet and a calorie-restricted low fat diet on body weight and cardiovascular risk factors in healthy women. J Clin Endocrinol Metab 88(4):1617-1623.
31. Briscoe, C. P., M. Tadayyon, J. L. Andrews, W. G. Benson, J. K. Chambers, M. M. Eilert, C. Ellis, et al. 2003. The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids. J Biol Chem 278(13):11303-11311.
32. Bronte-Stewart, B., A. Antonis, L. Eales, and J. F. Brock. 1956. Effects of feeding different fats on serum-cholesterol level. Lancet 270(6922):521-526.
33. Brophy, M. H. 1986. Zinc and childhood hyperactivity. Biol Psychiatry 21(7):704-705.
34. Broughton, K. S., C. S. Johnson, B. K. Pace, M. Liebman, and K. M. Kleppinger. 1997. Reduced asthma symptoms with n-3 fatty acid ingestion are related to 5-series leukotriene production. Am J Clin Nutr 65(4):1011-1017.
35. Brousseau, M. E., G. P. Eberhart, J. Dupuis, B. F. Asztalos, A. L. Goldkamp, E. J. Schaefer, and M. W. Freeman. 2000. Cellular cholesterol efflux in heterozygotes for tangier disease is markedly reduced and correlates with high density lipoprotein cholesterol concentration and particle size. J Lipid Res 41(7):1125-1135.
36. Brown, A. G., T. C. Smale, T. J. King, R. Hasenkamp, and R. H. Thompson. 1976. Crystal and molecular structure of compactin, a new antifungal metabolite from Penicillium brevicompactum. J Chem Soc [Perkin 1] (11): 1165-1170.
37. Brown, A. J., S. Jupe, and C. P. Briscoe. 2005. A family of fatty acid binding receptors. DNA Cell Biol 24(1):54-61.
38. Brown, M. S., and J. L. Goldstein. 1986. A receptor-mediated pathway for cholesterol homeostasis. Science 232(4746):34-47.
39. -. 1997. The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89(3):331-340.
40. Brownell, K., and K. B. Horgen. 2004. Food fight: The inside story of the food industry, America's obesity crisis, and what we can do about it. New York: McGraw-Hill Companies.
41. Brull, D. J., N. Serrano, F. Zito, L. Jones, H. E. Montgomery, A. Rumley, P. Sharma, et al. 2003. Human CRP gene polymorphism influences CRP levels: Implications for the prediction and pathogenesis of coronary heart disease. Arterioscler Thromb Vasc Biol 23(11):2063-2069.
42. Burgess, J. R., L. Stevens, W. Zhang, and L. Peck. 2000. Long-chain polyunsaturated fatty acids in children with attention-deficit hyperactivity disorder. Am J Clin Nutr 71(1 Suppl):327S-330S.
43. Burr, G. O., and M. M. Burr. 1929. A new deficiency disease produced by rigid exclusion of fat from the diet. J Biol Chem 82:345-367.
44. -. 1930. On the nature and role of the fatty acids essential in nutrition. J Biol Chem 86:587-621.
45. Busserolles, J., E. Gueux, E. Rock, A. Mazur, and Y. Rayssiguier. 2002. Substituting honey for refined carbohydrates protects rats from hypertriglyceridemic and prooxidative effects of fructose. J Nutr 132(11):3379-3382.
46. Calderon, F., and H. Y. Kim. 2004. Docosahexaenoic acid promotes neurite growth in hippocampal neurons. J Neurochem 90(4):979-988.
47. Callister, T. Q., P. Raggi, B. Cooil, N. J. Lippolis, and D. J. Russo. 1998. Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography. N Engl J Med 339(27):1972-1978.
48. Campos, H., J. J. Genest, Jr., E. Blijlevens, J. R. McNamara, J. L. Jenner, J. M. Ordovas, P. W. Wilson, and E. J. Schaefer. 1992. Low density lipoprotein particle size and coronary artery disease. Arterioscler Thromb 12(2):187-195.
49. Carlson, S. E., S. H. Werkman, J. M. Peeples, R. J. Cooke, and E. A. Tolley. 1993. Arachidonic acid status correlates with first year growth in preterm infants. Proc Natl Acad Sci USA 90(3):1073-1077.
50. Carlson, S. E., S. H. Werkman, and E. A. Tolley. 1996. Effect of long-chain n-3 fatty acid supplementation on visual acuity and growth of preterm infants with and without bronchopulmonary dysplasia. Am J Clin Nutr 63(5):687-697.
51. Carroll, M. D., D. A. Lacher, P. D. Sorlie, J. I. Cleeman, D. J. Gordon, M. Wolz, S. M. Grundy, and C. L. Johnson. 2005. Trends in serum lipids and lipoproteins of adults, 1960-2002. JAMA 294(14):1773-1781.
52. Casset, A., C. Marchand, A. Purohit, S. le Calve, B. Uring-Lambert, C. Donnay, P. Meyer, and F. de Blay. 2006. Inhaled formaldehyde exposure: Effect on bronchial response to mite allergen in sensitized asthma patients. Allergy 61(11):1344-1350.
53. Chen, C., and N. G. Bazan. 2005. Lipid signaling: Sleep, synaptic plasticity, and neuroprotection. Prostaglandins Other Lipid Mediat 77(1-4):65-76.
54. Cheung, B. M., I. J. Lauder, C. P. Lau, and C. R. Kumana. 2004. Meta-analysis of large randomized controlled trials to evaluate the impact of statins on cardiovascular outcomes. Br J Clin Pharmacol 57(5):640-651.
55. Chin, S. F., W. Liu, J. M. Storkson, Y. L. Ha, and M. W. Pariza. 1992. Dietary sources of conjugated dienoic isomers of linoleic acid, a newly recognized class of anticarcinogens. J Food Compos Anal 5:185-197.
56. Chisolm, G. M., G. Ma, K. C. Irwin, L. L. Martin, K. G. Gunderson, L. F. Linberg, D. W. Morel, and P. E. DiCorleto. 1994. 7 beta-hydroperoxycholest-5-en- 3 beta-ol, a component of human atherosclerotic lesions, is the primary cytotoxin of oxidized human low density lipoprotein. Proc Natl Acad Sci USA 91(24):11452-11456.
57. Choudhury, N., L. Tan, and A. S. Truswell. 1995. Comparison of palmolein and olive oil: Effects on plasma lipids and vitamin E in young adults. Am J Clin Nutr 61(5):1043-1051.
58. Christensen, O., and E. Christensen. 1988. Fat consumption and schizophrenia. Acta Psychiatr Scand 78(5):587-591.
59. Cimino, P. J., C. D. Keene, R. M. Breyer, K. S. Montine, and T. J. Montine. 2008. Therapeutic targets in prostaglandin E2 signaling for neurologic disease. Curr Med Chem 15(19):1863-1869.
60. Clària, J., and M. Romano. 2005. Pharmacological intervention of cyclooxygenase-2 and 5-lipoxygenase pathways: Impact on inflammation and cancer. Curr Pharm Des 11(26):3431-3447.
61. Clària, J., and C. N. Serhan. 1995. Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proc Natl Acad Sci USA 92(21):9475-9479.
62. Cleland, L. G., and M. J. James. 1997. Rheumatoid arthritis and the balance of dietary N-6 and N-3 essential fatty acids. Br J Rheumatol 36(5):513-514.
63. Cohen, P., and J. M. Friedman. 2004. Leptin and the control of metabolism: Role for stearoyl-CoA desaturase-1(SCD-1). J Nutr 134 (9):2455S-2463S.
64. Cohen, P., C. Zhao, X. Cai, J. M. Montez, S. C. Rohani, P. Feinstein, P. Mombaerts, and J. M. Friedman. 2001. Selective deletion of leptin receptor in neurons leads to obesity. J Clin Invest 108(8):1113-1121.
65. Coleman, D. L. 1978. Obese and diabetes: Two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia 14(3):141-148.
66. Colquhoun, I., and S. Bunday. 1981. A lack of essential fatty acids as a possible cause of hyperactivity in children. Med Hypotheses 7(5):673-679.
67. Commentary. 2000. Inflammation and Alzheimer's disease: Open peer commentary. Neurobiol Aging 21:383-421.
68. Consilvio, C., A. M. Vincent, and E. L. Feldman. 2004. Neuroinflammation, COX-2, and ALS-a dual role? Exp Neurol 187(1):1-10.
69. Cordain, Loren. 2009. Table of fatty acids in vegetable oils. The Paleo Diet 2009 [accessed June 30, 2009]. http://www.thepaleodiet.com/nutritional- tools/oils-table.html.
70. Corsini, A. 2003. The safety of HMG-CoA reductase inhibitors in special populations at high cardiovascular risk. Cardiovasc Drugs Ther 17(3):265-285.
71. Cotzias, G. C. 1971. Levodopa in the treatment of Parkinsonism. JAMA 218(13):1903-1908.
72. Cowburn, A. S., K. Sladek, J. Soja, L. Adamek, E. Nizankowska, A. Szczeklik, B. K. Lam, et al. 1998. Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest 101(4):834-846.
73. Cravatt, B. F., O. Prospero-Garcia, G. Siuzdak, N. B. Gilula, S. J. Henriksen, D. L. Boger, and R. A. Lerner. 1995. Chemical characterization of a family of brain lipids that induce sleep. Science 268(5216):1506-1509.
74. Cynshi, O., and R. Stocker. 2005. Inhibition of lipoprotein lipid oxidation. Handb Exp Pharmacol (170): 563-590.
75. Daly, M. 2003. Sugars, insulin sensitivity, and the postprandial state. Am J Clin Nutr 78(4):865S-872S.
76. D'Angelo, A., and J. Selhub. 1997. Homocysteine and thrombotic disease. Blood 90(1):1-11.
77. Davidson, M. H., and J. G. Robinson. 2007. Safety of aggressive lipid management. J Am Coll Cardiol 49(17):1753-1762.
78. Davignon, J., and L. A. Leiter. 2005. Ongoing clinical trials of the pleiotropic effects of statins. Vasc Health Risk Manag 1(1):29-40.
79. de la Presa Owens, S., and S. M. Innis. 1999. Docosahexaenoic and arachidonic acid prevent a decrease in dopaminergic and serotoninergic neurotransmitters in frontal cortex caused by a linoleic and alpha-linolenic acid deficient diet in formula-fed piglets. J Nutr 129(11):2088-2093.
80. -. 2000. Diverse, region-specific effects of addition of arachidonic and docosahexanoic acids to formula with low or adequate linoleic and alpha-linolenic acids on piglet brain monoaminergic neurotransmitters. Pediatr Res 48(1):125-130.
81. Demer, L. L., and Y. Tintut. 2003. Mineral exploration: Search for the mechanism of vascular calcification and beyond: The 2003 Jeffrey M. Hoeg Award lecture. Arterioscler Thromb Vasc Biol 23(10):1739-1743.
82. Denke, M. A., and S. M. Grundy. 1992. Comparison of effects of lauric acid and palmitic acid on plasma lipids and lipoproteins. Am J Clin Nutr 56(5):895-898.
83. Deutsch, D. G., M. S. Goligorsky, P. C. Schmid, R. J. Krebsbach, H. H. Schmid, S. K. Das, S. K. Dey, et al. 1997. Production and physiological actions of anandamide in the vasculature of the rat kidney. J Clin Invest 100(6):1538-1546.
84. Devane, W. A., L. Hanus, A. Breuer, R. G. Pertwee, L. A. Stevenson, G. Griffin, D. Gibson, A. Mandelbaum, A. Etinger, and R. Mechoulam. 1992. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258(5090):1946-1949.
85. Devlin, Thomas M. 2002. Textbook of biochemistry with clinical correlations. New York: Wiley-Liss.
86. Drachman, D. B., K. Frank, M. Dykes-Hoberg, P. Teismann, G. Almer, S. Przedborski, and J. D. Rothstein. 2002. Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS. Ann Neurol 52(6):771-778.
87. Dupuis, L., J. L. Gonzalez de Aguilar, H. Oudart, M. de Tapia, L. Barbeito, and J. P. Loeffler. 2004. Mitochondria in amyotrophic lateral sclerosis: A trigger and a target. Neurodegener Dis 1(6):245-254.
88. Dyerberg, J., and H. O. Bang. 1980. All cis-5, 8, 11, 14, 17 eicosapentaenoic acid and triene prostaglandins: Potential anti-thrombotic agents. Scand J Clin Lab Invest 40(7):589-593.
89. Eichner, J. E., S. T. Dunn, G. Perveen, D. M. Thompson, K. E. Stewart, and B. C. Stroehla. 2002. Apolipoprotein E polymorphism and cardiovascular disease: A HuGE review. Am J Epidemiol 155(6):487-495.
90. Elliott, S. S., N. L. Keim, J. S. Stern, K. Teff, and P. J. Havel. 2002. Fructose, weight gain, and the insulin resistance syndrome. Am J Clin Nutr 76(5):911-922.
91. el-Mesallamy, H., S. Suwailem, and N. Hamdy. 2007. Evaluation of C-reactive protein, endothelin-1, adhesion molecule (s), and lipids as inflammatory markers in type 2 diabetes mellitus patients. Mediators Inflamm 2007, article no. 73635.
92. Emerit, J., M. Edeas, and F. Bricaire. 2004. Neurodegenerative diseases and oxidative stress. Biomed Pharmacother 58(1):39-46.
93. Endo, A. 1992. The discovery and development of HMG-CoA reductase inhibitors. J Lipid Res 33(11):1569-1582.
94. Endres, S., R. Lorenz, and K. Loeschke. 1999. Lipid treatment of inflammatory bowel disease. Curr Opin Clin Nutr Metab Care 2(2):117-120.
95. Erickson, K. L. 1998. Is there a relation between dietary linoleic acid and cancer of the breast, colon, or prostate? Am J Clin Nutr 68(1):5-7.
96. Ferris, C. F., S. F. Lu, T. Messenger, C. D. Guillon, N. Heindel, M. Miller, G. Koppel, F. Robert Bruns, and N. G. Simon. 2006. Orally active vasopressin V1a receptor antagonist, SRX251, selectively blocks aggressive behavior. Pharmacol Biochem Behav 83(2):169-174.
97. Fleming, D. M., and D. L. Crombie. 1987. Prevalence of asthma and hay fever in England and Wales. Br Med J (Clin Res Ed) 294(6567):279-283.
98. Fride, E. 2002. Endocannabinoids in the central nervous system-an overview. Prostaglandins Leukot Essent Fatty Acids 66(2-3):221-233.
99. Fried, S. K., and S. P. Rao. 2003. Sugars, hypertriglyceridemia, and cardiovascular disease. Am J Clin Nutr 78(4):873S-880S.
100. Gaoni, Y., and R. Mechoulam. 1964. Isolation, structure, and partial synthesis of an active constituent of hashish. J Amer Chem Soc 86:1646.
101. Garcia Rodriguez, L. A., and A. Gonzalez-Perez. 2004. Inverse association between nonsteroidal anti-inflammatory drugs and prostate cancer. Cancer Epidemiol Biomarkers Prev 13(4):649-653.
102. Garcia-Rodriguez, L. A., and C. Huerta-Alvarez. 2001. Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs. Epidemiology 12(1):88-93.
103. Gardner, C. D., A. Kiazand, S. Alhassan, S. Kim, R. S. Stafford, R. R. Balise, H. C. Kraemer, and A. C. King. 2007. Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women: The A TO Z Weight Loss Study: A randomized trial. JAMA 297(9):969-977.
104. Garlid, K. D., M. Jaburek, and P. Jezek. 2001. Mechanism of uncoupling protein action. Biochem Soc Trans 29(6):803-806.
105. Geyelin, H. R. 1921. Fasting as a method of treating epilepsy. Medical Record 99:1037-1039.
106. Glew, Robert H. 2002. Lipid metabolism II: Pathways of metabolism of special lipids. In Textbook of biochemistry with clinical correlations. New York: Wiley-Liss.
107. Goldner, E. M., L. Hsu, P. Waraich, and J. M. Somers. 2002. Prevalence and incidence studies of schizophrenic disorders: A systematic review of the literature. Can J Psychiatry 47(9):833-843.
108. Goldstein, J. L., and M. S. Brown. 2001. Molecular medicine. The cholesterol quartet. Science 292(5520):1310-1312.
109. Gould, A. L., G. M. Davies, E. Alemao, D. D. Yin, and J. R. Cook. 2007. Cholesterol reduction yields clinical benefits: Meta-analysis including recent trials. Clin Ther 29(5):778-794.
110. Griffin, B. A., D. J. Freeman, G. W. Tait, J. Thomson, M. J. Caslake, C. J. Packard, and J. Shepherd. 1994. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: Relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis 106(2):241-253.
111. Grundy, S. M., J. I. Cleeman, C. N. Merz, H. B. Brewer, Jr., L. T. Clark, D. B. Hunninghake, R. C. Pasternak, S. C. Smith, Jr., and N. J. Stone. 2004. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110(2):227-239.
112. Ha, Y. L., N. K. Grimm, and M. W. Pariza. 1987. Anticarcinogens from fried ground beef: Heat-altered derivatives of linoleic acid. Carcinogenesis 8(12):1881-1887.
113. Ha, Y. L., J. Storkson, and M. W. Pariza. 1990. Inhibition of benzo (a) pyrene-induced mouse forestomach neoplasia by conjugated dienoic derivatives of linoleic acid. Cancer Res 50(4):1097-1101.
114. Hahnel, D., J. Thiery, T. Brosche, and B. Engelmann. 1999. Role of plasmalogens in the enhanced resistance of LDL to copper-induced oxidation after LDL apheresis. Arterioscler Thromb Vasc Biol 19(10):2431-2438.
115. Haley, S., J. Reed, B.-H. Lin, and A. Cook. 2005. Sweetener consumption in the United States: Distribution by demographics and product characteristics. U. S. Department of Agriculture 2005 [accessed June 30, 2009]. http://www.ers.usda.gov/Publications/SSS/aug05/sss24301/sss24301.pdf.
116. Hallahan, B., and M. R. Garland. 2004. Essential fatty acids and their role in the treatment of impulsivity disorders. Prostaglandins Leukot Essent Fatty Acids 71(4):211-216.
117. Harris, R. E., J. Beebe-Donk, and G. A. Alshafie. 2006. Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors. BMC Cancer 6:27.
118. Hartl, D. L., and E. W. Jones. 1991. Genetics: Analysis of genes and genomes. 5th ed. Sudbury, MA: Jones and Bartlett Publishers.
119. Hayes, C. E., M. T. Cantorna, and H. F. DeLuca. 1997. Vitamin D and multiple sclerosis. Proc Soc Exp Biol Med 216(1):21-27.
120. Hegsted, D. M., R. B. McGandy, M. L. Myers, and F. J. Stare. 1965. Quantitative effects of dietary fat on serum cholesterol in man. Am J Clin Nutr 17(5):281-295.
121. Heird, W. C., and A. Lapillonne. 2005. The role of essential fatty acids in development. Annu Rev Nutr 25:549-571.
122. Heller, A., T. Koch, J. Schmeck, and K. van Ackern. 1998. Lipid mediators in inflammatory disorders. Drugs 55(4):487-496.
123. Hibbeln, J. R. 2002. Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: A cross-national, ecological analysis. J Affect Disord 69(1-3):15-29.
124. Hibbeln, J. R., and N. Salem, Jr. 1995. Dietary polyunsaturated fatty acids and depression: When cholesterol does not satisfy. Am J Clin Nutr 62(1):1-9.
125. Higgins, H. L. 1916. The rapidity with which alcohol and some sugars may serve as nutrients. Am J Physiol 41:258-263.
126. Ho, L., W. Qin, P. N. Pompl, Z. Xiang, J. Wang, Z. Zhao, Y. Peng, et al. 2004. Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease. FASEB J 18(7):902-904.
127. Hobhouse, Henry. 1985. Sugar and the slave trade. In Seeds of change: Five plants that transformed mankind. London: Sedgwick and Jackson.
128. Honda, H., Y. Shimizu, and M. Rutter. 2005. No effect of MMR withdrawal on the incidence of autism: A total population study. J Child Psychol Psychiatry 46(6):572-579.
129. Horrobin, D. F., and M. S. Manku. 1980. Possible role of prostaglandin E1 in the affective disorders and in alcoholism. Br Med J 280(6228):1363-1366.
130. Hosoe, K., M. Kitano, H. Kishida, H. Kubo, K. Fujii, and M. Kitahara. 2007. Study on safety and bioavailability of ubiquinol (Kaneka QH) after single and 4-week multiple oral administration to healthy volunteers. Regul Toxicol Pharmacol 47(1):19-28.
131. Huffman, J., and E. H. Kossoff. 2006. State of the ketogenic diet (s) in epilepsy. Curr Neurol Neurosci Rep 6(4):332-340.
132. Humphrey, L. L., R. Fu, K. Rogers, M. Freeman, and M. Helfand. 2008. Homocysteine level and coronary heart disease incidence: A systematic review and meta-analysis. Mayo Clin Proc 83(11):1203-1212.
133. Huskisson, E. C., H. Berry, P. Gishen, R. W. Jubb, and J. Whitehead. 1995. Effects of antiinflammatory drugs on the progression of osteoarthritis of the knee. LINK Study Group. Longitudinal Investigation of Nonsteroidal Antiinflammatory Drugs in Knee Osteoarthritis. J Rheumatol 22(10):1941-1946.
134. Hussain, T., S. Gupta, V. M. Adhami, and H. Mukhtar. 2005. Green tea constituent epigallocatechin-3-gallate selectively inhibits COX-2 without affecting COX-1 expression in human prostate carcinoma cells. Int J Cancer 113(4):660-669.
135. Hutter-Paier, B., H. J. Huttunen, L. Puglielli, C. B. Eckman, D. Y. Kim, A. Hofmeister, R. D. Moir, et al. 2004. The ACAT inhibitor CP-113, 818 markedly reduces amyloid pathology in a mouse model of Alzheimer's disease. Neuron 44(2):227-238.
136. Hyakukoku, M., K. Higashiura, N. Ura, H. Murakami, K. Yamaguchi, L. Wang, M. Furuhashi, N. Togashi, and K. Shimamoto. 2003. Tissue-specific impairment of insulin signaling in vasculature and skeletal muscle of fructose-fed rats. Hypertens Res 26(2):169-176.
137. Inoue, M., H. Itoh, T. Tanaka, T. H. Chun, K. Doi, Y. Fukunaga, N. Sawada, et al. 2001. Oxidized LDL regulates vascular endothelial growth factor expression in human macrophages and endothelial cells through activation of peroxisome proliferator-activated receptor-gamma. Arterioscler Thromb Vasc Biol 21(4):560-566.
138. Insel, Paul A. 1990. Analgesic-antipyretics and antiinflammatory agents: Drugs employed in the treatment of rheumatoid arthritis and gout. In Goodman and Gilman's the pharmacological basis of therapeutics, ed. A. G. Gilman, T. W. Rall, A. S. Nies, and P. Taylor. New York: Pergamon Press.
139. Ip, C., S. F. Chin, J. A. Scimeca, and M. W. Pariza. 1991. Mammary cancer prevention by conjugated dienoic derivative of linoleic acid. Cancer Res 51(22):6118-6124.
140. Jakobisiak, M., and J. Golab. 2003. Potential antitumor effects of statins (review). Int J Oncol 23(4):1055-1069.
141. Janniger, C. K., and S. P. Racis. 1987. The arachidonic acid cascade: An immunologically based review. J Med 18(2):69-80.
142. Jialal, I., S. Devaraj, and S. K. Venugopal. 2004. C-reactive protein: Risk marker or mediator in atherothrombosis? Hypertension 44(1):6-11.
143. Jiang, R., D. C. Paik, J. L. Hankinson, and R. G. Barr. 2007. Cured meat consumption, lung function, and chronic obstructive pulmonary disease among United States adults. Am J Respir Crit Care Med 175(8):798-804.
144. Jones, P. J., P. B. Pencharz, and M. T. Clandinin. 1985. Whole body oxidation of dietary fatty acids: Implications for energy utilization. Am J Clin Nutr 42(5):769-777.
145. Jump, D. B. 2008. N-3 polyunsaturated fatty acid regulation of hepatic gene transcription. Curr Opin Lipidol 19(3):242-247.
146. Juni, P., A. W. Rutjes, and P. A. Dieppe. 2002. Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs? BMJ 324(7349):1287-1288.
147. Kaether, C., and C. Haass. 2004. A lipid boundary separates APP and secretases and limits amyloid beta-peptide generation. J Cell Biol 167(5):809-812.
148. Kamal-Bahl, S. J., T. Burke, D. Watson, and C. Wentworth. 2007. Discontinuation of lipid modifying drugs among commercially insured United States patients in recent clinical practice. Am J Cardiol 99(4):530-534.
149. Kannel, W. B., T. R. Dawber, A. Kagan, N. Revotskie, and J. Stokes. 1961. Factors of risk in the development of coronary heart disease: Six-year follow-up experience. Ann Intern Med 55:33-50.
150. Karg, E., P. Klivenyi, I. Nemeth, K. Bencsik, S. Pinter, and L. Vecsei. 1999. Nonenzymatic antioxidants of blood in multiple sclerosis. J Neurol 246(7):533-539.
151. Karmali, R. A. 1987. Eicosanoids in neoplasia. Prev Med 16(4):493-502.
152. Kelley, K. A., L. Ho, D. Winger, J. Freire-Moar, C. B. Borelli, P. S. Aisen, and G. M. Pasinetti. 1999. Potentiation of excitotoxicity in transgenic mice overexpressing neuronal cyclooxygenase-2. Am J Pathol 155(3):995-1004.
153. Keys, A. 1957. Diet and the epidemiology of coronary heart disease. JAMA 164(17):1912-1919.
154. -. 1980. Seven countries: A multivariate analysis of death and coronary heart disease. Cambridge, MA: Harvard University Press.
155. Keys, Ancel and Margaret. 1975. How to eat well and stay well the Mediterranean way. Garden City, N. Y.: Doubleday.
156. Kim, J., and B. E. Alger. 2004. Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus. Nat Neurosci 7(7):697-698.
157. Kirschenbauer, H. G. 1960. In Fats and oils: An outline of their chemistry and technology. New York: Reinhold Publishing Corp.
158. Kitajka, K., L. G. Puskas, A. Zvara, L. Hackler, Jr., G. Barcelo-Coblijn, Y. K. Yeo, and T. Farkas. 2002. The role of n-3 polyunsaturated fatty acids in brain: Modulation of rat brain gene expression by dietary n-3 fatty acids. Proc Natl Acad Sci USA 99(5):2619-2624.
159. Kitamura, Y., S. Shimohama, H. Koike, J. Kakimura, Y. Matsuoka, Y. Nomura, P. J. Gebicke-Haerter, and T. Taniguchi. 1999. Increased expression of cyclooxygenases and peroxisome proliferator-activated receptor-gamma in Alzheimer's disease brains. Biochem Biophys Res Commun 254(3):582-586.
160. Klenke, F. M., M. M. Gebhard, V. Ewerbeck, A. Abdollahi, P. E. Huber, and A. Sckell. 2006. The selective Cox-2 inhibitor Celecoxib suppresses angiogenesis and growth of secondary bone tumors: An intravital microscopy study in mice. BMC Cancer 6:9.
161. Klerman, G. L., and M. M. Weissman. 1989. Increasing rates of depression. JAMA 261(15):2229-2235.
162. Knijff, P. De, A. M. van den Maagdenberg, R. R. Frants, and L. M. Havekes. 1994. Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels. Hum Mutat 4:178-194.
163. Knott, C., G. Stern, and G. P. Wilkin. 2000. Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2. Mol Cell Neurosci 16(6):724-739.
164. Koenig, W., and M. B. Pepys. 2002. C-reactive protein risk prediction: Low specificity, high sensitivity. Ann Intern Med 136(7):550-552.
165. Kohlmeier, L., N. Simonsen, P. van't Veer, J. J. Strain, J. M. Martin-Moreno, B. Margolin, J. K. Huttunen, et al. 1997. Adipose tissue trans fatty acids and breast cancer in the European Community Multicenter Study on Antioxidants, Myocardial Infarction, and Breast Cancer. Cancer Epidemiol Biomarkers Prev 6(9):705-710.
166. Kojro, E., G. Gimpl, S. Lammich, W. Marz, and F. Fahrenholz. 2001. Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha-secretase ADAM 10. Proc Natl Acad Sci USA 98(10):5815-5820.
167. Kritchevsky, D. 1998. History of recommendations to the public about dietary fat. J Nutr 128(2 Suppl):449S-452S.
168. Kronmal, R. A., R. G. Hart, T. A. Manolio, R. L. Talbert, N. J. Beauchamp, and A. Newman. 1998. Aspirin use and incident stroke in the cardiovascular health study. CHS Collaborative Research Group. Stroke 29(5):887-894.
169. Kuczynski, B., and N. V. Reo. 2006. Evidence that plasmalogen is protective against oxidative stress in the rat brain. Neurochem Res 31(5):639-656.
170. Kummerow, F. A., Y. Kim, J. Hull, J. Pollard, P. Ilinov, D. L. Drossiev, and J. Valek. 1977. The influence of egg consumption on the serum cholesterol level in human subjects. Am J Clin Nutr 30(5):664-673.
171. Kump, L. R., J. F. Kasting, and R. G. Crane. 1999. The earth system. Upper Saddle River, NJ: Prentice-Hall.
172. Kurzok, R., and C. C. Lieb. 1930. Biochemical studies of human semen: The action of semen on the human uterus. Proc Soc Exp Biol Med 28:268-272.
173. Ladwig, K. H., B. Marten-Mittag, H. Lowel, A. Doring, and W. Koenig. 2005. C-reactive protein, depressed mood, and the prediction of coronary heart disease in initially healthy men: Results from the MONICA-KORA Augsburg Cohort Study 1984-1998. Eur Heart J 26(23):2537-2542.
174. Ladwig, K. H., B. Marten-Mittag, H. Lowel, A. Doring, and H. E. Wichmann. 2006. Synergistic effects of depressed mood and obesity on long-term cardiovascular risks in 1510 obese men and women: Results from the MONICA-KORA Augsburg Cohort Study 1984-1998. Int J Obes (Lond) 30(9):1408-1414.
175. Landers, Peter. 2006. Stalking cholesterol: How one scientist intrigued by molds found first statin. Wall Street Journal, January 9, 2006, A1.
176. Lands, W. E., T. Hamazaki, K. Yamazaki, H. Okuyama, K. Sakai, Y. Goto, and V. S. Hubbard. 1990. Changing dietary patterns. Am J Clin Nutr 51(6):991-993.
177. Langston, J. W., P. Ballard, J. W. Tetrud, and I. Irwin. 1983. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219(4587):979-980.
178. Larsson, S. C., M. Kumlin, M. Ingelman-Sundberg, and A. Wolk. 2004. Dietary long-chain n-3 fatty acids for the prevention of cancer: A review of potential mechanisms. Am J Clin Nutr 79(6):935-945.
179. Lauritzen, L., H. S. Hansen, M. H. Jorgensen, and K. F. Michaelsen. 2001. The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina. Prog Lipid Res 40(1-2):1-94.
180. Law, M. R., N. J. Wald, and A. R. Rudnicka. 2003. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: Systematic review and meta-analysis. BMJ 326(7404):1423-1427.
181. Lawrence, G. D. 1990. Effect of dietary lipids on adjuvant-induced arthritis in rats. Nutr Res 10:283-290.
182. Lawrence, G. D., G. Cohen, A. H. Aufses, and G. I. Slater. 1984. Lipid peroxidation in di methylhydrazine-induced colon cancer. Ann NY Acad Sci 435:441-443.
183. Lawrence, G. D., A. Mavi, and K. Meral. 2008. Promotion by phosphate of Fe (III) - and Cu (II)-catalyzed autoxidation of fructose. Carbohydr Res 343(4):626-635.
184. Lebeau, A., F. Terro, W. Rostene, and D. Pelaprat. 2004. Blockade of 12-lipoxygenase expression protects cortical neurons from apoptosis induced by beta-amyloid peptide. Cell Death Differ 11(8):875-884.
185. Lee, Y. S., C. H. Bailey, E. R. Kandel, and B. K. Kaang. 2008. Transcriptional regulation of long-term memory in the marine snail Aplysia. Mol Brain 1(1):3.
186. Libby, P. 2000. Changing concepts of atherogenesis. J Intern Med 247(3):349-358.
187. LIPID. 1998. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med 339(19):1349-1357.
188. Lipid Research Clinics Study Group. 1984. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. JAMA 251(3):351-364.
189. Liu, N. S. T., and O. A. Roels. 1980. The vitamins. In Modern nutrition in health and disease, ed. R. S. Goodhart and M. E. Shils. Philadelphia: Lea and Febiger.
190. Lock, A. L., B. A. Corl, D. M. Barbano, D. E. Bauman, and C. Ip. 2004. The anticarcinogenic effect of trans-11 18:1 is dependent on its conversion to cis-9, trans-11 CLA by delta9-desaturase in rats. J Nutr 134(10):2698-2704.
191. Lukiw, W. J., J. G. Cui, V. L. Marcheselli, M. Bodker, A. Botkjaer, K. Gotlinger, C. N. Serhan, and N. G. Bazan. 2005. A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J Clin Invest 115(10):2774-2783.
192. Lynn, A. B., and M. Herkenham. 1994. Localization of cannabinoid receptors and nonsaturable high-density cannabinoid binding sites in peripheral tissues of the rat: Implications for receptor-mediated immune modulation by cannabinoids. J Pharmacol Exp Ther 268(3):1612-1623.
193. Maccarrone, M., N. Battista, and D. Centonze. 2007. The endocannabinoid pathway in Huntington's disease: A comparison with other neurodegenerative diseases. Prog Neurobiol 81(5-6):349-379.
194. Macdonald, I. 1966. Influence of fructose and glucose on serum lipid levels in men and pre- and postmenopausal women. Am J Clin Nutr 18(5):369-372.
195. Macdonald, I., A. Keyser, and D. Pacy. 1978. Some effects, in man, of varying the load of glucose, sucrose, fructose, or sorbitol on various metabolites in blood. Am J Clin Nutr 31(8):1305-1311.
196. Mackenzie, I. R., and D. G. Munoz. 1998. Nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology in aging. Neurology 50(4):986-990.
197. Maffei, M., J. Halaas, E. Ravussin, R. E. Pratley, G. H. Lee, Y. Zhang, H. Fei, et al. 1995. Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1(11):1155-1161.
198. Makrides, M., R. A. Gibson, T. Udell, and K. Ried. 2005. Supplementation of infant formula with long-chain polyunsaturated fatty acids does not influence the growth of term infants. Am J Clin Nutr 81(5):1094-1101.
199. Malmros, H., and G. Wigand. 1957. The effect on serum-cholesterol of diets containing different fats. Lancet 273(6984):1-8.
200. Mandel, S., E. Grunblatt, P. Riederer, M. Gerlach, Y. Levites, and M. B. Youdim. 2003. Neuroprotective strategies in Parkinson's disease: An update on progress. CNS Drugs 17(10):729-762.
201. McCann, J. C., and B. N. Ames. 2005. Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals. Am J Clin Nutr 82(2):281-295.
202. McCully, K. S. 1998. Homocysteine, folate, vitamin B6, and cardiovascular disease. JAMA 279(5):392-393.
203. McDermott, C. M., G. J. LaHoste, C. Chen, A. Musto, N. G. Bazan, and J. C. Magee. 2003. Sleep deprivation causes behavioral, synaptic, and membrane excitability alterations in hippocampal neurons. J Neurosci 23(29):9687-9695.
204. McGarry, J. Denis. 2002. Lipid metabolism I: Utilization and storage of energy in lipid form. In Textbook of biochemistry with clinical correlations, ed. T. M. Devlin. New York: Wiley-Liss.
205. McGeer, P. L., M. Schulzer, and E. G. McGeer. 1996. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: A review of 17 epidemiologic studies. Neurology 47(2):425-432.
206. McGiff, J. C. 1987. Arachidonic acid metabolites. Prev Med 16:503-509.
207. McKinnon, H., E. Gherardi, M. Reidy, and D. Bowyer. 2006. Hepatocyte growth factor/scatter factor and MET are involved in arterial repair and atherogenesis. Am J Pathol 168(1):340-348.
208. Mechoulam, R., L. Hanus, and B. R. Martin. 1994. Search for endogenous ligands of the cannabinoid receptor. Biochem Pharmacol 48(8):1537-1544.
209. Medina, E. A., W. F. Horn, N. L. Keim, P. J. Havel, P. Benito, D. S. Kelley, G. J. Nelson, and K. L. Erickson. 2000. Conjugated linoleic acid supplementation in humans: Effects on circulating leptin concentrations and appetite. Lipids 35(7):783-788.
210. Melamed, J., J. M. Einhorn, and M. M. Ittmann. 1997. Allelic loss on chromosome 13q in human prostate carcinoma. Clin Cancer Res 3(10):1867-1872.
211. Menotti, A., H. Blackburn, D. Kromhout, A. Nissinen, H. Adachi, and M. Lanti. 2001. Cardiovascular risk factors as determinants of 25-year all-cause mortality in the seven countries study. Eur J Epidemiol 17(4):337-346.
212. Menzies, G. 2003. 1421: The year China discovered America. New York: Perennial/Harper-Collins Publishers.
213. Miller, G. 2003. Society for Neuroscience meeting: Neurons get connected via glia. Science 302(5649):1323.
214. Miller, G. W. 2007. Paraquat: The red herring of Parkinson's disease research. Toxicol Sci 100(1):1-2.
215. Minghetti, L. 2004. Cyclooxygenase-2(COX-2) in inflammatory and degenerative brain diseases. J Neuropathol Exp Neurol 63 (9):901-910.
216. Mishra, S. K., S. C. Watkins, and L. M. Traub. 2002. The autosomal recessive hypercholesterolemia (ARH) protein interfaces directly with the clathrin-coat machinery. Proc Natl Acad Sci USA 99(25):16099-16104.
217. Mitchell, E. A., M. G. Aman, S. H. Turbott, and M. Manku. 1987. Clinical characteristics and serum essential fatty acid levels in hyperactive children. Clin Pediatr (Phila) 26(8):406-411.
218. Mitchell, J. A., P. Akarasereenont, C. Thiemermann, R. J. Flower, and J. R. Vane. 1993. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 90(24):11693-11697.
219. Mizuno, Y., and K. Ohta. 1986. Regional distributions of thiobarbituric acid-reactive products, activities of enzymes regulating the metabolism of oxygen free radicals, and some of the related enzymes in adult and aged rat brains. J Neurochem 46(5):1344-1352.
220. Moisse, K., and M. J. Strong. 2006. Innate immunity in amyotrophic lateral sclerosis. Biochim Biophys Acta 1762(11-12):1083-1093.
221. Morel, D. W., J. R. Hessler, and G. M. Chisolm. 1983. Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid. J Lipid Res 24(8):1070-1076.
222. Mori, T. A., and R. J. Woodman. 2006. The independent effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors in humans. Curr Opin Clin Nutr Metab Care 9(2):95-104.
223. MSNBC. 2006. New York City passes trans fat ban [accessed June 30, 2009]. http://www.msnbc.msn. com/id/16051436/.
224. Mudd, S. H., F. Skovby, H. L. Levy, K. D. Pettigrew, B. Wilcken, R. E. Pyeritz, G. Andria, et al. 1985. The natural history of homocysteine due to cystathionine beta synthase defi-ciency. Am J Hum Gen 37:1-31.
225. Multiple Risk Factor Intervention Trial Research Group. 1982. Multiple Risk Factor Intervention Trial: Risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research Group. JAMA 248(12):1465-1477.
226. Murch, S. J., P. A. Cox, S. A. Banack, J. C. Steele, and O. W. Sacks. 2004. Occurrence of betamethylamino-1-alanine (BMAA) in ALS/PDC patients from Guam. Acta Neurol Scand 110(4):267-269.
227. Nagakura, T., S. Matsuda, K. Shichijyo, H. Sugimoto, and K. Hata. 2000. Dietary supplementation with fish oil rich in omega-3 polyunsaturated fatty acids in children with bronchial asthma. Eur Respir J 16(5):861-865.
228. Nagan, N., and R. A. Zoeller. 2001. Plasmalogens: Biosynthesis and functions. Prog Lipid Res 40(3):199-229.
229. Nauss, K. M., M. Locniskar, and P. M. Newberne. 1983. Effect of alterations in the quality and quantity of dietary fat on 1, 2-dimethylhydrazine-induced colon tumorigenesis in rats. Cancer Res 43(9):4083-4090.
230. Navab, M., G. M. Ananthramaiah, S. T. Reddy, B. J. Van Lenten, B. J. Ansell, G. C. Fonarow, K. Vahabzadeh, et al. 2004. The oxidation hypothesis of atherogenesis: The role of oxidized phospholipids and HDL. J Lipid Res 45(6):993-1007.
231. Ng, T. K., K. C. Hayes, G. F. DeWitt, M. Jegathesan, N. Satgunasingam, A. S. Ong, and D. Tan. 1992. Dietary palmitic and oleic acids exert similar effects on serum cholesterol and lipoprotein profiles in normocholesterolemic men and women. J Am Coll Nutr 11(4):383-390.
232. Nishigaki, I., M. Hagihara, H. Tsunekawa, M. Maseki, and K. Yagi. 1981. Lipid peroxide levels of serum lipoprotein fractions of diabetic patients. Biochem Med 25(3):373-378.
233. Norat, T., S. Bingham, P. Ferrari, N. Slimani, M. Jenab, M. Mazuir, K. Overvad, et al. 2005. Meat, fish, and colorectal cancer risk: The European Prospective Investigation into cancer and nutrition. J Natl Cancer Inst 97(12):906-916.
234. Okamoto, K., T. Kihira, T. Kondo, G. Kobashi, M. Washio, S. Sasaki, T. Yokoyama, et al. 2007. Nutritional status and risk of amyotrophic lateral sclerosis in Japan. Amyotroph Lateral Scler 8(5):300-304.
235. Okuyama, H., T. Kobayashi, and S. Watanabe. 1996. Dietary fatty acids-the N-6/N-3 balance and chronic elderly diseases: Excess linoleic acid and relative N-3 deficiency syndrome seen in Japan. Prog Lipid Res 35(4):409-457.
236. Oliveros, J. C., M. K. Jandali, M. Timsit-Berthier, R. Remy, A. Benghezal, A. Audibert, and J. M. Moeglen. 1978. Vasopressin in amnesia. Lancet 311(8054):42.
237. Olsen, S. F., P. Grandjean, P. Weihe, and T. Videro. 1993. Frequency of seafood intake in pregnancy as a determinant of birth weight: Evidence for a dose dependent relationship. J Epidemiol Community Health 47(6):436-440.
238. Olsen, S. F., and N. J. Secher. 2002. Low consumption of seafood in early pregnancy as a risk factor for preterm delivery: Prospective cohort study. BMJ 324(7335):447.
239. Oteiza, P. I., O. D. Uchitel, F. Carrasquedo, A. L. Dubrovski, J. C. Roma, and C. G. Fraga. 1997. Evaluation of antioxidants, protein, and lipid oxidation products in blood from sporadic amyotrophic lateral sclerosis patients. Neurochem Res 22(4):535-539.
240. Palinski, W., M. E. Rosenfeld, S. Yla-Herttuala, G. C. Gurtner, S. S. Socher, S. W. Butler, S. Parthasarathy, T. E. Carew, D. Steinberg, and J. L. Witztum. 1989. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci USA 86(4):1372-1376.
241. Panagiotakos, D. B., C. Pitsavos, C. Chrysohoou, S. Kavouras, and C. Stefanadis. 2005. The associations between leisure-time physical activity and inflammatory and coagulation markers related to cardiovascular disease: The ATTICA study. Prev Med 40(4):432-437.
242. Panagiotakos, D. B., C. Pitsavos, C. Chrysohoou, E. Tsetsekou, C. Papageorgiou, G. Christodoulou, and C. Stefanadis. 2004. Inflammation, coagulation, and depressive symptomatology in cardiovascular disease-free people: The ATTICA study. Eur Heart J 25(6):492-499.
243. Paoletti, R., C. Bolego, and A. Cignarella. 2005. Lipid and non-lipid effects of statins. Handb Exp Pharmacol (170): 365-388.
244. Parker, G., N. A. Gibson, H. Brotchie, G. Heruc, A. M. Rees, and D. Hadzi-Pavlovic. 2006. Omega-3 fatty acids and mood disorders. Am J Psychiatry 163(6):969-978.
245. Pasinetti, G. M. 1998. Cyclooxygenase and inflammation in Alzheimer's disease: Experimental approaches and clinical interventions. J Neurosci Res 54(1):1-6.
246. Pauling, Linus. 1970. Vitamin C and the common cold. San Fransisco: W. H. Freeman and Co.
247. Payne, A. 2001. Nutrition and diet in the clinical management of multiple sclerosis. J Hum Nutr Diet 14(5):349-357.
248. Pearce, M. L., and S. Dayton. 1971. Incidence of cancer in men on a diet high in polyunsaturated fat. Lancet 297(7697):464-467.
249. Peet, M. 2004. Nutrition and schizophrenia: Beyond omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids 70(4):417-422.
250. Pekkanen, J., A. Nissinen, S. Punsar, and M. J. Karvonen. 1989. Serum cholesterol and risk of accidental or violent death in a 25-year follow-up: The Finnish cohorts of the Seven Countries Study. Arch Intern Med 149(7):1589-1591.
251. Peterson, A. M., and W. F. McGhan. 2005. Pharmacoeconomic impact of non-compliance with statins. Pharmacoeconomics 23(1):13-25.
252. Pirozzo, S., C. Summerbell, C. Cameron, and P. Glasziou. 2002. Advice on low-fat diets for obesity. Cochrane Database Syst Rev (2): CD003640.
253. Pollan, Michael. 2001. The botany of desire: A plant's eye-view of the world. New York: Random House.
254. Porter, A. C., J. M. Sauer, M. D. Knierman, G. W. Becker, M. J. Berna, J. Bao, G. G. Nomikos, et al. 2002. Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. J Pharmacol Exp Ther 301(3):1020-1024.
255. Pozuelo, L., G. Tesar, J. Zhang, M. Penn, K. Franco, and W. Jiang. 2009. Depression and heart disease: What do we know, and where are we headed? Cleve Clin J Med 76(1):59-70.
256. Pryor, W. A. 2000. Vitamin E and heart disease: Basic science to clinical intervention trials. Free Radic Biol Med 28(1):141-164.
257. Puri, B. K., S. J. Counsell, G. Hamilton, A. J. Richardson, and D. F. Horrobin. 2001. Eicosapentaenoic acid in treatment-resistant depression associated with symptom remission, structural brain changes and reduced neuronal phospholipid turnover. Int J Clin Pract 55(8):560-563.
258. Putnam, J. J., and J. E. Allshouse. 1999. Food consumption, prices and expenditures, 1970-1997. Statistical Bulletin No. 965. U. S. Department of Agriculture, Economic Research Services [accessed June 30, 2009]. http://usda.mannlib.cornell.edu/usda/reports/general/sb/sb965.pdf.
259. Quinn, M. T., S. Parthasarathy, L. G. Fong, and D. Steinberg. 1987. Oxidatively modified low density lipoproteins: A potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Natl Acad Sci USA 84(9):2995-2998.
260. Randall, M. D., D. A. Kendall, and S. O'Sullivan. 2004. The complexities of the cardiovascular actions of cannabinoids. Br J Pharmacol 142(1):20-26.
261. Ravnskov, U., P. J. Rosch, and M. C. Sutter. 2005. Intensive lipid lowering with atorvastatin in coronary disease. N Engl J Med 353(1):93-96; author reply 93-96.
262. Reaven, P., S. Parthasarathy, B. J. Grasse, E. Miller, D. Steinberg, and J. L. Witztum. 1993. Effects of oleate-rich and linoleate-rich diets on the susceptibility of low density lipoprotein to oxidative modification in mildly hypercholesterolemic subjects. J Clin Invest 91(2):668-676.
263. Reszko, A. E., T. Kasumov, F. David, K. A. Jobbins, K. R. Thomas, C. L. Hoppel, H. Brunengraber, and C. Des Rosiers. 2004. Peroxisomal fatty acid oxidation is a substantial source of the acetyl moiety of malonyl-CoA in rat heart. J Biol Chem 279(19):19574-19579.
264. Richard, D., K. Kefi, U. Barbe, P. Bausero, and F. Visioli. 2008. Polyunsaturated fatty acids as antioxidants. Pharmacol Res 57(6):451-455.
265. Richardson, A. J., C. M. Calvin, C. Clisby, D. R. Schoenheimer, P. Montgomery, J. A. Hall, G. Hebb, E. Westwood, J. B. Talcott, and J. F. Stein. 2000. Fatty acid deficiency signs predict the severity of reading and related difficulties in dyslexic children. Prostaglandins Leukot Essent Fatty Acids 63(1-2):69-74.
266. Richardson, A. J., I. J. Cox, J. Sargentoni, and B. K. Puri. 1997. Abnormal cerebral phospholipid metabolism in dyslexia indicated by phosphorus-31 magnetic resonance spectroscopy. NMR Biomed 10(7):309-314.
267. Ridker, P. M., J. E. Buring, N. R. Cook, and N. Rifai. 2003. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: An 8-year follow-up of 14 719 initially healthy American women. Circulation 107(3):391-397.
268. Ridker, P. M., E. Danielson, F. A. Fonseca, J. Genest, A. M. Gotto, Jr., J. J. Kastelein, W. Koenig, et al. 2008. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359(21):2195-2207.
269. Rolls, B. J., E. L. Morris, and L. S. Roe. 2002. Portion size of food affects energy intake in normal-weight and overweight men and women. Am J Clin Nutr 76(6):1207-1213.
270. Rondeau, V. 2002. A review of epidemiologic studies on aluminum and silica in relation to Alzheimer's disease and associated disorders. Rev Environ Health 17(2):107-121.
271. Rong, J. X., S. Rangaswamy, L. Shen, R. Dave, Y. H. Chang, H. Peterson, H. N. Hodis, G. M. Chisolm, and A. Sevanian. 1998. Arterial injury by cholesterol oxidation products causes endothelial dysfunction and arterial wall cholesterol accumulation. Arterioscler Thromb Vasc Biol 18(12):1885-1894.
272. Ross, B. M., I. McKenzie, I. Glen, and C. P. Bennett. 2003. Increased levels of ethane, a noninvasive marker of n-3 fatty acid oxidation, in breath of children with attention deficit hyperactivity disorder. Nutr Neurosci 6(5):277-281.
273. Roth, G. J., and P. W. Majerus. 1975. The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein. J Clin Invest 56(3):624-632.
274. Roux, L., M. Pratt, T. O. Tengs, M. M. Yore, T. L. Yanagawa, J. Van Den Bos, C. Rutt, R. C. Brownson, K. E. Powell, G. Heath, H. W. Kohl, 3rd, S. Teutsch, J. Cawley, I. M. Lee, L. West, and D. M. Buchner. 2008. Cost effectiveness of community-based physical activity interventions. Am J Prev Med 35(6):578-588.
275. Rudin, D. O. 1981. The major psychoses and neuroses as omega-3 essential fatty acid deficiency syndrome: Substrate pellagra. Biol Psychiatry 16(9):837-850.
276. Ruyter, B., C. Rosjo, B. Grisdale-Helland, G. Rosenlund, A. Obach, and M. S. Thomassen. 2003. Influence of temperature and high dietary linoleic acid content on esterification, elongation, and desaturation of PUFA in Atlantic salmon hepatocytes. Lipids 38(8):833-840.
277. Sagredo, O., J. A. Ramos, A. Decio, R. Mechoulam, and J. Fernandez-Ruiz. 2007. Cannabidiol reduced the striatal atrophy caused 3-nitropropionic acid in vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1 and adenosine A2A receptors. Eur J Neurosci 26(4):843-851.
278. Sakai, M., M. Oimomi, and M. Kasuga. 2002. Experimental studies on the role of fructose in the development of diabetic complications. Kobe J Med Sci 48(5-6):125-136.
279. Samaha, F. F., G. D. Foster, and A. P. Makris. 2007. Low-carbohydrate diets, obesity, and metabolic risk factors for cardiovascular disease. Curr Atheroscler Rep 9(6):441-447.
280. Samaha, F. F., N. Iqbal, P. Seshadri, K. L. Chicano, D. A. Daily, J. McGrory, T. Williams, M. Williams, E. J. Gracely, and L. Stern. 2003. A low-carbohydrate as compared with a low-fat diet in severe obesity. N Engl J Med 348(21):2074-2081.
281. Sanak, M., B. D. Levy, C. B. Clish, N. Chiang, K. Gronert, L. Mastalerz, C. N. Serhan, and A. Szczeklik. 2000. Aspirin-tolerant asthmatics generate more lipoxins than aspirinintolerant asthmatics. Eur Respir J 16(1):44-49.
282. Sanda, Bill. 2004. The double danger of high fructose corn syrup. Weston A. Price Foundation, February 19, 2004 [accessed June 30, 2009]. http://www.westonaprice.org/modernfood/highfrucose.html.
283. Sanders, T. A. 1999. Essential fatty acid requirements of vegetarians in pregnancy, lactation, and infancy. Am J Clin Nutr 70(3 Suppl):555S-559S.
284. Sato, Y., N. Hotta, N. Sakamoto, S. Matsuoka, N. Ohishi, and K. Yagi. 1979. Lipid peroxide level in plasma of diabetic patients. Biochem Med 21(1):104-107.
285. Scandinavian Simvastatin Survival Study. 1994. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease. Lancet 344(8934):1383-1389.
286. Schlanger, S., M. Shinitzky, and D. Yam. 2002. Diet enriched with omega-3 fatty acids alleviates convulsion symptoms in epilepsy patients. Epilepsia 43(1):103-104.
287. Schmitz, G., and J. Ecker. 2008. The opposing effects of n-3 and n-6 fatty acids. Prog Lipid Res 47(2):147-155.
288. Seierstad, S. L., I. Seljeflot, O. Johansen, R. Hansen, M. Haugen, G. Rosenlund, L. Froyland, and H. Arnesen. 2005. Dietary intake of differently fed salmon: The influence on markers of human atherosclerosis. Eur J Clin Invest 35(1):52-59.
289. Serhan, C. N. 2001. Lipoxins and aspirin-triggered 15-epi-lipoxins are endogenous components of antiinflammation: Emergence of the counterregulatory side. Arch Immunol Ther Exp (Warsz) 49(3):177-188.
290. Serhan, C. N., M. Arita, S. Hong, and K. Gotlinger. 2004. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers. Lipids 39(11):1125-1132.
291. Serhan, C. N., S. Hong, K. Gronert, S. P. Colgan, P. R. Devchand, G. Mirick, and R. L. Moussignac. 2002. Resolvins: A family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med 196(8):1025-1037.
292. Serhan, C. N., and E. Oliw. 2001. Unorthodox routes to prostanoid formation: New twists in cyclooxygenase-initiated pathways. J Clin Invest 107(12):1481-1489.
293. Shafiq, N., S. Malhotra, P. Pandhi, and A. Grover. 2005. The "statinth" wonder of the world: A panacea for all illnesses or a bubble about to burst. J Negat Results Biomed 4:3.
294. Shaftel, S. S., J. A. Olschowka, S. D. Hurley, A. H. Moore, and M. K. O'Banion. 2003. COX-3: A splice variant of cyclooxygenase-1 in mouse neural tissue and cells. Brain Res Mol Brain Res 119(2):213-215.
295. Sharman, I. M. 1981. Glycogen loading: Advantages but possible disadvantages. Br J Sports Med 15:64-67.
296. Sheaff Greiner, R. C., Q. Zhang, K. J. Goodman, D. A. Giussani, P. W. Nathanielsz, and J. T. Brenna. 1996. Linoleate, alpha-linolenate, and docosahexaenoate recycling into saturated and monounsaturated fatty acids is a major pathway in pregnant or lactating adults and fetal or infant rhesus monkeys. J Lipid Res 37(12):2675-2686.
297. Sheng, H., J. Shao, J. D. Morrow, R. D. Beauchamp, and R. N. DuBois. 1998. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res 58(2):362-366.
298. Sheng, M., and M. J. Kim. 2002. Postsynaptic signaling and plasticity mechanisms. Science 298(5594):776-780.
299. Shepherd, J., S. M. Cobbe, I. Ford, C. G. Isles, A. R. Lorimer, P. W. MacFarlane, J. H. McKillop, and C. J. Packard. 1995. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 333(20):1301-1307.
300. Sherwood, Lauralee. 2004. Human physiology: From cells to systems. 5th ed. Belmont, CA: Brooks/Cole-Thomson Learning.
301. Shimizu, I., Y. R. Ma, Y. Mizobuchi, F. Liu, T. Miura, Y. Nakai, M. Yasuda, et al. 1999. Effects of Sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats. Hepatology 29(1):149-160.
302. Silva, M., M. L. Matthews, C. Jarvis, N. M. Nolan, P. Belliveau, M. Malloy, and P. Gandhi. 2007. Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy. Clin Ther 29(2):253-260.
303. Simon, A. M., M. B. Manigrasso, and J. P. O'Connor. 2002. Cyclo-oxygenase 2 function is essential for bone fracture healing. J Bone Miner Res 17(6):963-976.
304. Simons, K., and D. Toomre. 2000. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 1(1):31-39.
305. Simopoulos, A. P. 1991. Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr 54(3):438-463.
306. -. 2002a. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother 56(8):365-379.
307. -. 2002b. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr 21(6):495-505.
308. Sinclair, A. J., D. Begg, M. Mathai, and R. S. Weisinger. 2007. Omega 3 fatty acids and the brain: Review of studies in depression. Asia Pac J Clin Nutr 16(Suppl 1):391-397.
309. Sing, C. F., and E. A. Boerwinkle. 1987. Genetic architecture of inter-individual variability in apolipoprotein, lipoprotein and lipid phenotypes. Ciba Found Symp 130:99-127.
310. Singh, M. 2005. Essential fatty acids, DHA and human brain. Indian J Pediatr 72(3):239-242.
311. Slaga, T. J., A. J. Klein-Szanto, L. L. Triplett, L. P. Yotti, and K. E. Trosko. 1981. Skin tumorpromoting activity of benzoyl peroxide, a widely used free radical-generating compound. Science 213(4511):1023-1025.
312. Smith, S. C., Jr. 1996. Risk-reduction therapy: The challenge to change. Presented at the 68th cientific sessions of the American Heart Association, November 13, 1995, Anaheim, CA. Circulation 93(12):2205-2211.
313. Smuts, C. M., M. Huang, D. Mundy, T. Plasse, S. Major, and S. E. Carlson. 2003. A randomized trial of docosahexaenoic acid supplementation during the third trimester of pregnancy. Obstet Gynecol 101(3):469-479.
314. Snyderman, S. E. 1980. Nutrition in infancy and adolescence. In Modern nutrition in health and disease, ed. R. S. Goodhart and M. E. Shils. Philadelphia: Lea and Febiger.
315. Sohal, R. S., and M. J. Forster. 2007. Coenzyme Q, oxidative stress and aging. Mitochondrion 7(Suppl):S103-S111.
316. Sohal, R. S., S. Kamzalov, N. Sumien, M. Ferguson, I. Rebrin, K. R. Heinrich, and M. J. Forster. 2006. Effect of coenzyme Q10 intake on endogenous coenzyme Q content, mitochondrial electron transport chain, antioxidative defenses, and life span of mice. Free Radic Biol Med 40(3):480-487.
317. Song, Y. G., H. M. Kwon, J. M. Kim, B. K. Hong, D. S. Kim, A. J. Huh, K. H. Chang, et al. 2000. Serologic and histopathologic study of Chlamydia pneumoniae infection in atherosclerosis: A possible pathogenetic mechanism of atherosclerosis induced by Chlamydia pneumoniae. Yonsei Med J 41(3):319-327.
318. Stanhope, K. L., and P. J. Havel. 2008. Fructose consumption: Potential mechanisms for its effects to increase visceral adiposity and induce dyslipidemia and insulin resistance. Curr Opin Lipidol 19(1):16-24.
319. Steinberg, D. 1997. Lewis A. Conner Memorial Lecture: Oxidative modification of LDL and atherogenesis. Circulation 95(4):1062-1071.
320. -. 2002. Atherogenesis in perspective: Hypercholesterolemia and inflammation as partners in crime. Nat Med 8(11):1211-1217.
321. -. 2004. Thematic review series: The pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy: Part I. J Lipid Res 45(9):1583-1593.
322. Steinberg, G., W. H. Slaton, Jr., D. R. Howton, and J. F. Mead. 1956. Metabolism of essential fatty acids. IV. Incorporation of linoleate into arachidonic acid. J Biol Chem 220(1):257-264.
323. Stenson, W. F., D. Cort, J. Rodgers, R. Burakoff, K. DeSchryver- Kecskemeti, T. L. Gramlich, and W. Beeken. 1992. Dietary supplementation with fish oil in ulcerative colitis. Ann Intern Med 116(8):609-614.
324. Stordy, B. J. 2000. Dark adaptation, motor skills, docosahexaenoic acid, and dyslexia. Am J Clin Nutr 71(1 Suppl):323S-326S.
325. Strange, P. G. 1992. Brain biochemistry and brain disorders. Oxford: Oxford University Press.
326. Strayer, D., M. Belcher, T. Dawson, B. Delaney, J. Fine, B. Flickenger, P. Friedman, et al. 2006. Food fats and oils. 9th ed. Washington, D. C.: Institute of Shortening and Edible Oils [accessed June 30, 2009]. http://www.iseo.org./foodfats.htm.
327. Strittmatter, W. J., and A. D. Roses. 1995. Apolipoprotein E and Alzheimer disease. Proc Natl Acad Sci USA 92(11):4725-4727.
328. Subbanagounder, G., N. Leitinger, D. C. Schwenke, J. W. Wong, H. Lee, C. Rizza, A. D. Watson, K. F. Faull, A. M. Fogelman, and J. A. Berliner. 2000. Determinants of bioactivity of oxidized phospholipids: Specific oxidized fatty acyl groups at the sn-2 position. Arterioscler Thromb Vasc Biol 20(10):2248-2254.
329. Tannenbaum, A. 1942. The genesis and growth of tumors. III. Effects of high fat diets. Cancer Research 2:468-475.
330. Taylor, K. E., C. J. Higgins, C. M. Calvin, J. A. Hall, T. Easton, A. M. McDaid, and A. J. Richardson. 2000. Dyslexia in adults is associated with clinical signs of fatty acid deficiency. Prostaglandins Leukot Essent Fatty Acids 63(1-2):75-78.
331. Temple, N. J. 1996. Dietary fats and coronary heart disease. Biomed Pharmacother 50(6-7):261-268.
332. Thiele, E. A. 2003. Assessing the efficacy of antiepileptic treatments: The ketogenic diet. Epilepsia 44(Suppl 7):26-29.
333. Thijssen, M. A., and Mensink. 2005. Fatty acids and atherosclerosis risk. In Atherosclerosis: Diet and drugs, ed. A. von Eckardstein, 170:165-194. Handbook of Experimental Pharmacology series. Berlin-Heidelberg: Springer-Verlag.
334. Thompson, C. M., and R. C. Grafström. 2008. Mechanistic considerations for formaldehydeinduced bronchoconstriction involving S-nitrosoglutathione reductase. J Toxicol Environ Health A 71(3):244-248.
335. Tokudome, S., M. Kojima, S. Suzuki, H. Ichikawa, Y. Ichikawa, M. Miyata, K. Maeda, et al. 2006. Marine n-3 fatty acids and colorectal cancer: Is there a real link? Cancer Epidemiol Biomarkers Prev 15(2):406-407.
336. Tsiplakou, E., and G. Zervas. 2008. The effect of dietary inclusion of olive tree leaves and grape marc on the content of conjugated linoleic acid and vaccenic acid in the milk of dairy sheep and goats. J Dairy Res 75(3):270-278.
337. Uauy, R., D. R. Hoffman, E. E. Birch, D. G. Birch, D. M. Jameson, and J. Tyson. 1994. Safety and efficacy of omega-3 fatty acids in the nutrition of very low birth weight infants: Soy oil and marine oil supplementation of formula. J Pediatr 124(4):612-620.
338. Ujike, H., and Y. Morita. 2004. New perspectives in the studies on endocannabinoid and cannabis: Cannabinoid receptors and schizophrenia. J Pharmacol Sci 96(4):376-381.
339. U. S. Census Bureau. 2000. Statistical abstracts of the United States: The national data book. Washington, DC: U. S. Census Bureau.
340. U. S. Census Bureau. 2005. Income, poverty, and health insurance coverage in the United States: 2004. Washington, DC: U. S. Government Printing Office [accessed June 30, 2009]. http://www.census.gov/prod/2005pubs/p60-229.pdf.
341. Vaddadi, K. S., C. J. Gilleard, R. H. Mindham, and R. Butler. 1986. A controlled trial of prostaglandin E1 precursor in chronic neuroleptic resistant schizophrenic patients. Psychopharmacology (Berl) 88(3):362-367.
342. Valenza, M., and E. Cattaneo. 2006. Cholesterol dysfunction in neurodegenerative diseases: Is Huntington's disease in the list? Prog Neurobiol 80(4):165-176.
343. van den Berg, E., J. M. Dekker, G. Nijpels, R. P. Kessels, L. J. Kappelle, E. H. de Haan, R. J. Heine, C. D. Stehouwer, and G. J. Biessels. 2008. Cognitive functioning in elderly persons with type 2 diabetes and metabolic syndrome: The Hoorn study. Dement Geriatr Cogn Disord 26(3):261-269.
344. Van Gaal, L., X. Pi-Sunyer, J. P. Despres, C. McCarthy, and A. Scheen. 2008. Efficacy and safety of rimonabant for improvement of multiple cardiometabolic risk factors in overweight/obese patients: Pooled 1-year data from the Rimonabant in Obesity (RIO) program. Diabetes Care 31(Suppl 2):S229-S240.
345. Vane, J. R. 1971. Inhibition of prostaglandin synthesis as a mechanism of action for aspirinlike drugs. Nat New Biol 231(25):232-235.
346. Varadarajan, S., S. Yatin, M. Aksenova, and D. A. Butterfield. 2000. Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity. J Struct Biol 130(2-3):184-208.
347. Veiraiah, A. 2005. Hyperglycemia, lipoprotein glycation, and vascular disease. Angiology 56(4):431-438.
348. Vetrivel, K. S., H. Cheng, W. Lin, T. Sakurai, T. Li, N. Nukina, P. C. Wong, H. Xu, and G. Thinakaran. 2004. Association of gamma-secretase with lipid rafts in post-Golgi and endosome membranes. J Biol Chem 279(43):44945-44954.
349. Visioli, F., C. Colombo, and C. Galli. 1998. Oxidation of individual fatty acids yields different profiles of oxidation markers. Biochem Biophys Res Commun 245(2):487-489.
350. von Euler, U. S. 1983. History and development of prostaglandins. Gen Pharmacol 14(1):3-6.
351. Vreugdenhil, M., C. Bruehl, R. A. Voskuyl, J. X. Kang, A. Leaf, and W. J. Wadman. 1996. Polyunsaturated fatty acids modulate sodium and calcium currents in CA1 neurons. Proc Natl Acad Sci USA 93(22):12559-12563.
352. Wang, Y. 2001. Cross-national comparison of childhood obesity: The epidemic and the relationship between obesity and socioeconomic status. Int J Epidemiol 30(5):1129-1136.
353. Warner, T. D., F. Giuliano, I. Vojnovic, A. Bukasa, J. A. Mitchell, and J. R. Vane. 1999. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis. Proc Natl Acad Sci USA 96(13):7563-7568.
354. Watson, R. T., and J. E. Pessin. 2001. Subcellular compartmentalization and trafficking of the insulin-responsive glucose transporter, GLUT4. Exp Cell Res 271(1):75-83.
355. Wattenberg, L. W. 1983. Inhibition of neoplasia by minor dietary constituents. Cancer Res 43(5 Suppl):2448S-2453S.
356. Weber, W., and S. Newmark. 2007. Complementary and alternative medical therapies for attention-deficit/hyperactivity disorder and autism. Pediatr Clin North Am 54(6):983-1006.
357. Wentworth, P., Jr., J. Nieva, C. Takeuchi, R. Galve, A. D. Wentworth, R. B. Dilley, G. A. DeLaria, et al. 2003. Evidence for ozone formation in human atherosclerotic arteries. Science 302(5647):1053-1056.
358. Whitmer, R. A., E. P. Gunderson, E. Barrett-Connor, C. P. Quesenberry, Jr., and K. Yaffe. 2005. Obesity in middle age and future risk of dementia: A 27 year longitudinal population based study. BMJ 330(7504):1360.
359. WHO. 1984. WHO cooperative trial on primary prevention of ischaemic heart disease with clofibrate to lower serum cholesterol: Final mortality follow-up. Report of the Committee of Principal Investigators. Lancet 324(8403):600-604.
360. Willerson, J. T., and P. M. Ridker. 2004. Inflammation as a cardiovascular risk factor. Circulation 109(21 Suppl 1):II2-10.
361. WIN-NIDDK. 2007. Statistics related to overweight and obesity. Weight-Control Information Network, National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK), National Institutes of Health, Washington, DC [accessed June 18, 2008]. http://win. niddk.nih.gov/statistics/index.htm.
362. Wolozin, B., W. Kellman, P. Ruosseau, G. G. Celesia, and G. Siegel. 2000. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3- methyglutaryl coenzyme A reductase inhibitors. Arch Neurol 57(10):1439-1443.
363. Wood, Philip A. 2006. How fat works. Cambridge, MA: Harvard University Press.
364. Woollett, L. A., D. K. Spady, and J. M. Dietschy. 1992. Saturated and unsaturated fatty acids independently regulate low density lipoprotein receptor activity and production rate. J Lipid Res 33(1):77-88.
365. WOSCOPS. 1998. Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation 97(15):1440-1445.
366. Wright, J. M. 2002. The double-edged sword of COX-2 selective NSAIDs. CMAJ 167(10):1131-1137.
367. Wu, B. J., A. J. Hulbert, L. H. Storlien, and P. L. Else. 2004. Membrane lipids and sodium pumps of cattle and crocodiles: An experimental test of the membrane pacemaker theory of metabolism. Am J Physiol Regul Integr Comp Physiol 287(3):R633-R641.
368. Yancy, W. S., Jr., M. K. Olsen, J. R. Guyton, R. P. Bakst, and E. C. Westman. 2004. A lowcarbohydrate, ketogenic diet versus a low-fat diet to treat obesity and hyperlipidemia: A randomized, controlled trial. Ann Intern Med 140(10):769-777.
369. Yang, H., and C. Chen. 2008. Cyclooxygenase-2 in synaptic signaling. Curr Pharm Des 14(14):1443-1451.
370. Yang, H., J. Zhang, K. Andreasson, and C. Chen. 2008. COX-2 oxidative metabolism of endocannabinoids augments hippocampal synaptic plasticity. Mol Cell Neurosci 37(4):682-695.
371. Yavin, E., A. Brand, and P. Green. 2002. Docosahexaenoic acid abundance in the brain: A biodevice to combat oxidative stress. Nutr Neurosci 5(3):149-157.
372. Yermakova, A. V., J. Rollins, L. M. Callahan, J. Rogers, and M. K. O'Banion. 1999. Cyclooxygenase-1 in human Alzheimer and control brain: Quantitative analysis of expression by microglia and CA3 hippocampal neurons. J Neuropathol Exp Neurol 58(11):1135-1146.
373. Yoon, J. H., and S. J. Baek. 2005. Molecular targets of dietary polyphenols with antiinflammatory properties. Yonsei Med J 46(5):585-596.
374. Young, L. R., and M. Nestle. 2002. The contribution of expanding portion sizes to the US obesity epidemic. Am J Public Health 92(2):246-249.
375. Young-Xu, Y., S. Jabbour, R. Goldberg, C. M. Blatt, T. Graboys, B. Bilchik, and S. Ravid. 2003. Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease. Am J Cardiol 92(12):1379-1383.
376. Yudkoff, M., Y. Daikhin, I. Nissim, O. Horyn, A. Lazarow, B. Luhovyy, and S. Wehrli. 2005. Response of brain amino acid metabolism to ketosis. Neurochem Int 47(1-2):119-128.
377. Zambell, K. L., N. L. Keim, M. D. Van Loan, B. Gale, P. Benito, D. S. Kelley, and G. J. Nelson. 2000. Conjugated linoleic acid supplementation in humans: Effects on body composition and energy expenditure. Lipids 35(7):777-782.
378. Zammit, V. A., I. J. Waterman, D. Topping, and G. McKay. 2001. Insulin stimulation of hepatic triacylglycerol secretion and the etiology of insulin resistance. J Nutr 131(8):2074-2077.
379. Zhang, W., T. Wang, Z. Pei, D. S. Miller, X. Wu, M. L. Block, B. Wilson, Y. Zhou, J. S. Hong, and J. Zhang. 2005. Aggregated alpha-synuclein activates microglia: A process leading to disease progression in Parkinson's disease. FASEB J 19(6):533-542.
380. Zhang, Y., R. Proenca, M. Maffei, M. Barone, L. Leopold, and J. M. Friedman. 1994. Positional cloning of the mouse obese gene and its human homologue. Nature 372(6505):425-432.
381. Zhao, W., P. S. Devamanoharan, and S. D. Varma. 2000. Fructose induced deactivation of antioxidant enzymes: Preventive effect of pyruvate. Free Radic Res 33(1):23-30.
382. Zhao, Z., D. J. Lange, A. Voustianiouk, D. MacGrogan, L. Ho, J. Suh, N. Humala, M. Thiyagarajan, J. Wang, and G. M. Pasinetti. 2006. A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis. BMC Neurosci 7:29.
383. Zock, P. L., and M. B. Katan. 1998. Linoleic acid intake and cancer risk: A review and metaanalysis. Am J Clin Nutr 68(1):142-153.
384. Zubay, Geoffrey. 1998. Biochemistry. 4th ed. Dubuque, IA: William C. Brown Publishers.